Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong · Delayed Price · Currency is HKD 182.80
-6.50 (-3.43%)
At close: Jun 8, 2026
HKG:2637 Market Cap
HKG:2637 has a market cap or net worth of 14.9 billion as of June 8, 2026.
Market Cap
14.90B
Enterprise Value
13.54B
Revenue
648.05M
Ranking
n/a
PE Ratio
66.79
Stock Price
182.80
Market Cap Chart
Since October 20, 2025, HKG:2637's market cap has increased from 8.20B to 14.90B, an increase of 81.67%. That is a compound annual growth rate of 160.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 14.90B | 39.19% |
| Dec 31, 2025 | 10.70B | 30.52% |
| Oct 20, 2025 | 8.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Medical System Holdings | 25.78B |
| Simcere Pharmaceutical Group | 25.35B |
| Sunshine Lake Pharma | 20.24B |
| Grand Pharmaceutical Group | 18.10B |
| The United Laboratories International Holdings | 17.08B |
| Consun Pharmaceutical Group | 12.14B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |
| CanSino Biologics | 10.08B |